A sound institutional collaboration begins with a shared problem and a bounded question, not a partnership announcement. Before a pilot, clarify each party’s objective, authority, contribution, data and materials, confidentiality, background and newly created intellectual property, budget, decision rights, risk owner, evaluation method and exit conditions. Use counsel and authorized technology-transfer, procurement, privacy, security and research offices where relevant. A collaboration conversation or pilot is not an investment, license, endorsement or commitment to scale.
Start with the joint problem
Write the problem from both sides. The institution may need a service improvement, research translation, learner or patient outcome, staff workflow change, or better infrastructure. The venture may need access to domain knowledge, a lawful test environment, product feedback, a distribution pathway or a technically meaningful use case. These aims can overlap without being identical. State any tension before work begins.
Define the affected users and decision owner. Ask whether the institution has authority to permit the proposed test, whether another department owns the data or budget, and whether existing procurement, ethics, safety or security policies apply. Do not imply that a single contact can authorize the whole institution.
The collaboration canvas
Create a one-page working record with these fields:
| Area | Questions to settle |
|---|---|
| Shared problem | Which user and workflow are in scope? What is explicitly out of scope? |
| Intended learning | What decision should the collaboration inform? What would count as useful evidence? |
| Roles and authority | Who sponsors, operates, approves, reviews risk and makes the next decision? |
| Contributions | What time, expertise, software, facilities, data, materials or funding may each party contribute? |
| Data and confidentiality | What information may be exchanged? What access, security, retention, deletion and incident rules apply? |
| Intellectual property | What background material is each party bringing? Who reviews new results, inventions, software and publication rights? |
| Economics and procurement | How are costs, purchasing, licensing, revenue, support and liability discussed by authorized parties? |
| Evaluation | What baseline, sample, measures, period, limitations and independent review are needed? |
| Governance | Who reviews changes, incidents, conflicts, accessibility and scope creep? |
| Exit | How does either party stop? What happens to data, materials, work product and communications? |
This is an agenda, not contract language. Applicable terms differ by jurisdiction, institution, funding source, field and public/private status.
Choose the right instrument only after scope is clear
Different collaborations may require different agreement paths. NIST’s Technology Partnerships Office publicly describes several instruments used by NIST, including non-disclosure, material-transfer, software-transfer, data-transfer, research collaboration and cooperative research and development agreements. Its published pages also show that their funding, confidentiality, IP and licensing features differ. These NIST-specific descriptions are examples of how formal structures can vary; they are not available templates or legal advice for another party. Start with the institution’s authorized contracting, research, legal and technology-transfer offices.
A practical sequence is: exploratory discussion with no confidential exchange; jointly written scope; institutional review of data, IP, ethics, procurement and security; a negotiated written instrument; small bounded test; documented decision; and separate approval before any scale-up or public statement.
Make the evidence useful to both sides
Write a pilot plan before it starts. Include the user group, workflow, baseline, success criteria, measurement method, participant consent or authorization, exclusion rules, data handling, failure escalation, burden on staff, duration and decision owner. Define what results will be shared and whether the findings can be published. A pilot that only demonstrates software access is not evidence of impact. A favorable result in one context may not transfer to another population, campus, clinic, department or operating system.
Use a predeclared decision path: proceed to a larger test; revise the product or workflow; extend discovery because a key uncertainty remains; or stop. Report negative or inconclusive findings accurately. Do not convert an exploratory meeting, memorandum, paid trial or research collaboration into a public partnership claim without permission and evidence that the description is accurate.
Worked hypothetical
A fictional university research office and an early-stage software venture discuss whether a tool could support a repetitive, non-sensitive administrative workflow. Before any student or research data is shared, the parties identify the process owner, the procurement route, authorized data, background software, intended test and stop condition. The institution’s designated offices determine which agreement and review steps apply. The test uses synthetic or approved data, documents staff correction effort and records whether the workflow merits a second evaluation. This scenario is fictional and does not describe an existing Silicon Founders relationship.
Common failure points
- “Strategic partnership” is announced before the scope or permission is defined.
- One enthusiastic stakeholder is treated as budget authority or institutional approval.
- Data, background IP and new work product are discussed only after a pilot begins.
- A pilot has no baseline, decision rule, owner or stop condition.
- Free access is mistaken for procurement demand or long-term distribution.
- Each party expects the other to fund staff, integration, support or liability.
- Public communications name people, institutions or outcomes without approval.
FAQ
Does a pilot create a partnership? Not necessarily. Use the exact description authorized by both parties and supported by the written arrangement.
Should founders send confidential documents in an introduction? No. Begin with non-confidential context and use the organization’s approved secure process only after an authorized review.
Who owns IP created during a collaboration? The answer depends on law, contracts, funding conditions, employee/inventor status and institution policy. Get qualified counsel and authorized institutional review before work begins.
Does an MoU guarantee funding or distribution? No. Its effect depends on its wording and context. Do not infer obligations or commercial outcomes from a label.
Limits
This guide is a discussion framework, not legal, procurement, research-ethics, data-protection or investment advice. Formal agreements must be reviewed by authorized representatives and qualified counsel.
Source notes — reviewed 2026-10-31
- NIST, Collaborative Agreements — examples and stated boundaries of NIST’s own collaboration mechanisms; not a generic template.
- NSF, About I-Corps — example of institutional and industry collaboration around commercialization learning; no claim that Silicon Founders participates in NSF programs.
This guide is Silicon Founders editorial material for general educational purposes. Examples are hypothetical. It is not investment, legal, accounting, technical assurance or regulatory advice, and it does not describe an active investment, partnership, client mandate or company result. Source links are provided for context; the editorial framework is Silicon Founders’ synthesis.